You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

stage IC ovarian epithelial cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Among Reproductive Age Gynecological and Breast Cancer

Recruiting
  • Anatomic Stage I Breast Cancer AJCC v8
  • +29 more
  • Healthcare Activity
  • Survey Administration
  • Houston, Texas
    M D Anderson Cancer Center
Nov 2, 2022

Fallopian Tube Carcinoma, Primary Peritoneal Carcinoma, Stage I Ovarian Cancer Trial in Buffalo (procedure, drug, other)

Completed
  • Fallopian Tube Carcinoma
  • +14 more
  • Diagnostic Microscopy
  • +2 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Oct 5, 2021

Remote Telemonitoring of Patient-Generated Physiologic Health

Recruiting
  • Clinical Stage 0 Esophageal Adenocarcinoma AJCC v8
  • +171 more
  • Patient Monitoring
  • Questionnaire Administration
  • Duarte, California
    City of Hope Medical Center
Aug 15, 2022

Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Carcinoma Trial in Oklahoma City (Paclitaxel, Cisplatin IP)

Terminated
Has Results
  • Ovarian Cancer
  • +3 more
  • Paclitaxel, Cisplatin IP
  • Oklahoma City, Oklahoma
    University of Oklahoma Health Sciences Center
Apr 28, 2021

Ovarian Cancer Trial in Goyang (Cisplatin)

Not yet recruiting
  • Ovarian Cancer
  • Goyang, Gyeonggi, Korea, Republic of
    National Cancer Center
Apr 24, 2023

Epithelial Ovarian Cancer: A Retrospective Study

Recruiting
  • Epithelial Ovarian Cancer
  • Hematologic features
  • Shanghai, Shanghai, China
    Renji Hospital Affiliated to Shanghai Jiao Tong University Schoo
Oct 16, 2023

Stage III Fallopian Tube Cancer AJCC v7, Stage III Ovarian Cancer AJCC v6 and v7, Stage III Primary Peritoneal Cancer AJCC v7

Active, not recruiting
  • Stage III Fallopian Tube Cancer AJCC v7
  • +14 more
  • Minneapolis, Minnesota
  • +1 more
Jan 27, 2023

Ovarian Cancer Trial in Birmingham (Carboplatin, olaparibp, embro)

Not yet recruiting
  • Ovarian Cancer
  • Birmingham, Alabama
    O'Neal Comprehensive Cancer Center at UAB
Jul 18, 2023

Early Screening of Epithelial Ovarian Cancer

Not yet recruiting
  • Ovarian Cancer
  • +2 more
  • Fragmentomics
  • (no location specified)
Jun 26, 2023

Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Tumor, Fallopian Tube Mucinous Tumor Trial in Rochester

Active, not recruiting
  • Fallopian Tube Clear Cell Adenocarcinoma
  • +22 more
  • Laboratory Biomarker Analysis
  • Multi-epitope Folate Receptor Alpha-loaded Dendritic Cell Vaccine
  • Rochester, Minnesota
    Mayo Clinic
Oct 7, 2022

The Immune Landscape of Epithelial Ovarian Cancer

Recruiting
  • Epithelial Ovarian Cancer
  • Collection of tumor samples, blood and vaginal and rectal swabs
  • Bellinzona, Switzerland
    Oncology Institute of Southern Switzerland
Aug 2, 2023

A Prospective, Randomized Controlled Study of Cyclophosphamide,

Not yet recruiting
  • Epithelial Ovarian Cancer
  • Shijiazhuang, Hebei, China
    Hebei
Aug 20, 2023

Safety of Niraparib in Korean Primary and Recurrent Epithelial

Completed
  • Epithelial Ovarian Cancer
  • Seoul, Korea, Republic of
    Department of Obstetrics and Gynecology, University of Ulsan Col
Oct 11, 2023

Ovarian Epithelial Cancer Trial (99mTC nanocolloid albumin injection, ICG injection)

Not yet recruiting
  • Ovarian Epithelial Cancer
  • 99mTC nanocolloid albumin injection
  • ICG injection
  • (no location specified)
Jul 6, 2023

Ovarian Cancer, Stage III Ovarian Cancer, Stage IV Ovarian Cancer Trial in Toronto (Niraparib)

Not yet recruiting
  • Ovarian Cancer
  • +3 more
  • Toronto, Ontario, Canada
    Sunnybrook Research Institute
Jul 18, 2023

ctDNA Predicts Recurrence of Advanced Ovarian Cancer After

Recruiting
  • Ovarian Cancer Stage IV
  • Ovarian Cancer Stage III
    • Guangzhou, Guangdong, China
      Sun Yat-Sen Memorial Hospital
    Aug 30, 2023

    Ovarian Cancer Stage III, Ovarian Cancer Stage IV Trial (Artificial Intelligence)

    Not yet recruiting
    • Ovarian Cancer Stage III
    • Ovarian Cancer Stage IV
    • Artificial Intelligence
    • (no location specified)
    Aug 24, 2023

    Stage III Ovarian Cancer, Stage IV Ovarian Cancer, Epithelial Ovarian Cancer Trial in Baltimore (procedure, drug, other)

    Recruiting
    • Stage III Ovarian Cancer
    • +6 more
    • Cytoreductive Surgery (CRS)
    • +6 more
    • Baltimore, Maryland
      Mercy Medical Center
    Aug 30, 2022

    HER2-positive Breast Cancer, Stage III Ovarian Epithelial Cancer, Stage III Ovarian Germ Cell Tumor Trial in Seattle

    Active, not recruiting
    • HER2-positive Breast Cancer
    • +8 more
    • pNGVL3-hICD vaccine
    • +6 more
    • Seattle, Washington
      Fred Hutchinson Cancer Research Center/University of Washington
    Nov 1, 2022

    Epithelial Ovarian Cancer Trial (ROMA score evaluation)

    Not yet recruiting
    • Epithelial Ovarian Cancer
    • ROMA score evaluation
    • (no location specified)
    Aug 7, 2023

    ctDNA Methylation for Epithelial Ovarian Cancer

    Recruiting
    • Epithelial Ovarian Cancer
    • +7 more
    • CDO1 and HOXA9 methylation assay
    • Beijing, Beijing, China
      Lei Li
    Mar 24, 2023

    Ovarian Cancer Trial (Huaier granule)

    Not yet recruiting
    • Ovarian Cancer
    • Huaier granule
    • (no location specified)
    Feb 28, 2023

    Advanced Epithelial Ovarian Cancer Trial in Cairo (Carboplatin/paclitaxel)

    Completed
    • Advanced Epithelial Ovarian Cancer
    • Cairo, Egypt
      Pharmacology and toxicology department, Faculty of Pharmacy, Cai
    Jul 19, 2023

    Ovarian Cancer, Fallopian Tube Carcinoma, Peritoneal Carcinoma Trial in Italy (carboplatin and paclitaxel followed by surgery)

    Active, not recruiting
    • Ovarian Cancer
    • +2 more
    • carboplatin and paclitaxel followed by surgery
    • Bologna, Italy
    • +4 more
    Dec 28, 2022

    Epithelial Ovarian Carcinoma Stage III, Epithelial Ovarian Carcinoma Stage IV, Fallopian Tube Carcinoma Stage III Trial in China

    Recruiting
    • Epithelial Ovarian Carcinoma Stage III
    • +5 more
    • nab-paclitaxel combined with carboplatin
    • Guangzhou, Guangdong, China
    • +10 more
    Feb 19, 2023